<DOC>
	<DOCNO>NCT02395900</DOCNO>
	<brief_summary>To study effect Flaxseed supplement lipid profile , liver enzymes , inflammatory factor hepatic fibrosis patient Nonalcoholic Steatohepatitis ( NASH ) , 50 patient refer Gastrointestinal ( GI ) clinic steatosis grade 2 3 randomly allocate receive placebo 30 gram Flaxseed powder 12 week ; group advise adherence investigator ' diet exercise program . At first end intervention , lipid profile , liver enzymes , inflammatory marker , liver fibrosis assess compare group .</brief_summary>
	<brief_title>The Effects Flaxseed Supplement Biochemical Factors Hepatic Fibrosis Patients With Nonalcoholic Fatty Liver Disease</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Age 18 70 year Body Mass Index ( BMI ) 2540 Serum alaninaminotransferase 1.5 fold upper limit normal range Sonographic finding compatible hepatic steatosis ( degree 2 ) Diabetes Taking kind antibiotic two week recruitment History alcohol consumption pregnancy lactation Professional athletes Other liver disease ( viral/etc ) Use drug calcium channel blocker , high dose synthetic estrogen , methotrexate , amiodarone , steroid , chloroquine , immunosuppressive drug , lipidlowering agent , metformin vitamin E A history Hypertension , Cardiovascular disease , Pulmonary disease , Renal disease &amp; Celiac disease ; Cirrhosis History Upper GI surgery / Prior surgical procedure jejunoileal jejunocolic bypass , gastroplasty Following program lose weight recent 3 mo A history hypothyroidism Cushing 's syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>